Related Experiment Video
Updated: Apr 6, 2026
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
10:33
Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
1.3K
68Ga-Based radiopharmaceuticals: production and application relationship
1Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala SE-751 85, Sweden. irina.velikyan@akademiska.se.
Molecules (Basel, Switzerland)
|July 21, 2015
Summary
Gallium-68 (68Ga) significantly advances clinical research and routine positron emission tomography (PET) for earlier diagnostics and personalized medicine. This review covers 68Ga production, radiopharmaceuticals, and their clinical applications.
Area of Science:
- Nuclear medicine
- Radiochemistry
- Medical imaging
Background:
- Gallium-68 (68Ga) is a key radionuclide for positron emission tomography (PET) imaging.
- Its increasing use supports advancements in diagnostics and individualized medicine.
Purpose of the Study:
- To review the production of 68Ga and 68Ga-based radiopharmaceuticals.
- To discuss their applications in clinical research and routine diagnostics.
- To consider the impact of regulatory requirements on these applications.
Main Methods:
- Literature review of 68Ga production methods.
- Analysis of current and emerging 68Ga-based imaging agents.
- Discussion of regulatory considerations for radiopharmaceutical development.
Main Results:
- 68Ga production is crucial for expanding PET applications.
- Various 68Ga-based agents enable targeted, pre-targeted, and non-targeted imaging.
- Regulatory compliance is essential for clinical translation.
Conclusions:
- 68Ga plays a vital role in enhancing diagnostic capabilities and personalized medicine through PET.
- Understanding production and regulatory landscapes is key for future development and clinical integration of 68Ga radiopharmaceuticals.
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
763
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
763
01:29Positron Emission Tomography
8.1K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.1K